1- Costantino L, Boraschi D. Drug Discov Today. 2012;17(7-8):367-378.
2- De Jong WH, Borm PJ. Int J Nanomedicine. 2008;3(2):133-149.
3- Dykman L, Khlebtsov N. Chem Soc Rev. 2012;41(6):2256-2282.
4- Huo S, Jin S, Ma X, Xue X, Yang K, Kumar A, et al. ACS nano. 2014;8(6):5852-5862.
5- Sonavane G, Tomoda K, Makino K. Colloids Surf B. 2008;66(2):274-280.
6- Vinogradov SV, Bronich TK, Kabanov AV. Adv. 2002;54(1):135-147.
7- Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. SM. 2005;1(3):325-327.
8- Lin C-C, Yeh Y-C, Yang C-Y, Chen C-L, Chen G-F, Chen C-C, et al. J AM CHEM SOC. 2002;124(14):3508-3509.
9- Pan Yu, Neuss S, Leifert A, Fischler M, Wen F, Simon U, et al. SM. 2007;3(11):1941-1949.
10- Welsch W, Klein C, Von Schickfus M, Hunklinger S. Anal Chem. 1996;68(13):2000-2004.
11- Anker JN, Hall WP, Lyandres O, Shah NC, Zhao J, Van Duyne RP. Biosensing with Plasmonic Nanosensors. Nanoscience and Technology: A Collection of Reviews from Nature Journals: World Scientific; 2010. p. 308-319.
12- Gannon CJ, Patra CR, Bhattacharya R, Mukherjee P, Curley SA. J Nanobiotechnology. 2008;6(1):2.
13- Gobin AM, Lee MH, Halas NJ, James WD, Drezek RA, West JL. Nano Lett. 2007;7(7):1929-1934.
14- Jain RK. Annu Rev Biomed Eng. 1999;1(1):241-263.
15- Viudez AJ, Madueno R, Pineda T, Blazquez M. J Phys Chem B. 2006;110(36):17840-17847.
16- Hesabi M, Behjatmanesh-Ardakani R. COMPUT THEOR CHEM. 2017;1117:61-80.
17- Sierpe R, Noyong M, Simon U, Aguayo D, Huerta J, Kogan MJ, et al. Carbohydr Polym. 2017;177:22-31.
18- Wang R, Yue L, Yu Y, Zou X, Song D, Liu K, et al. J Phys Chem C. 2016;120(26):14410-14415.
19- Hesabi M. Phys Chem Res. 2018;6(1):115-132.
20- Hesabi M, Behjatmanesh-Ardakani R. Appl Surf Sci. 2018;427:112-125.
21- Erb N, Harms DO, Janka-Schaub G. CANCER CHEMOTH PHARM. 1998;42(4):266-272.
22- Krynetskaia NF, Feng JY, Krynetski EY, Garcia JV, Panetta JC, Anderson KS, et al. FASEB J. 2001;15(11):1902-1908.
23- Narukawa M, Cortado R, Hacke K, An DS, Shimizu S, Kasahara N, et al. Int J Antimicrob Agents. 2013;42(13):S128- S129.
24- Lanzkron S, Strouse JJ, Wilson R, Beach MC, Haywood C, Park H, et al. Ann Intern Med. 2008;148(12):939-955.
25- Liebelt EL, Balk SJ, Faber W, Fisher JW, Hughes CL, Lanzkron SM, et al. Birth Defects Research Part B: Developmental and Reproductive Toxicology. 2007;80(4):259-366.
26- Meo A, Cassinerio E, Castelli R, Bignamini D, Perego L, Cappellini M. INT J LAB HEMATOL. 2008;30(5):425-431.
27- شهابی ج ، شاه آبادی ح ا ، علوی س ا ، کوهی مفتخر اصفهانی م ، ارجمند م ، ا سیف کردی ع ، اکبرزاده ع ، مجله تازههای بیوتکنولوژی سلولی- مولکولی، 1394: 5، 20.
28- Malär R, Sjöö F, Rentsch K, Hassan M, Güngör T. Therapeutic Drug Monitoring Is Essential for Intravenous Busulfan Therapy in Pediatric Hematopoietic Stem Cell Recipients. Pediatric transplantation. 2011;15(6):580-588.
29- Nieto Y, Thall P, Valdez B, Andersson B, Popat U, Anderlini P, et al. High-Dose Infusional Gemcitabine Combined with Busulfan and Melphalan with Autologous Stem-Cell Transplantation in Patients with Refractory Lymphoid Malignancies. BIOL BLOOD MARROW TR 2012;18(11):1677-1686.
30- Schiffman K, Bensinger W, Appelbaum F, Rowley S, Lilleby K, Clift R, et al. Phase Ii Study of High-Dose Busulfan, Melphalan and Thiotepa with Autologous Peripheral Blood Stem Cell Support in Patients with Malignant Disease. Bone marrow transplantation. 1996;17(6):943-950.
31- Iwamoto T, Hiraku Y, Oikawa S, Mizutani H, Kojima M, Kawanishi S. CANCER SCI. 2004;95(5):454-458.
32- Blum V, Scheffler M, Gehrke R, Hanke F, Havu P, Ren X, Reuter K. The Fritz Haber Institute Ab Initio Molecular Simulation Package (Fhiaims). 2009, http://www.fhi-berlin.mpg.de/aims.
33- Kohanoff J. Electronic Structure Calculations for Solids and Molecules: Theory and Computational Methods: Cambridge University Press; 2006.
34- Perdew JP, Burke K, Ernzerhof M. Phys Rev Lett. 1996;77(18):3865-3668.
35- Hamann D, Schlüter M, Chiang C. Phys Rev Lett. 1979;43(20):1494-1497.
36- Garrett M MDS, Goodsell, Michael E. Pique, William “Lindy” Lindstrom, Ruth Huey, Stefano Forli, William E. Hart, Scott Halliday, Rik Belew and Arthur
37- Hetényi C, Van Der Spoel D. Efficient Docking of Peptides to Proteins without Prior Knowledge of the Binding Site. Protein science. 2002;11(7):1729-1737.
38- Hetényi C, Van Der Spoel D. Blind Docking of Drug‐Sized Compounds to Proteins with up to a Thousand Residues. FEBS letters. 2006;580(5):1447-1450.
39- http://www.rcsb.org.
